Literature DB >> 25451067

Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable of expressing a foreign gene.

Tomohiro Ishikawa1, Makoto Abe2, Michiaki Masuda2.   

Abstract

Japanese encephalitis virus (JEV) genotype V was originally isolated in Malaysia in 1952 and has long been restricted to the area. In 2009, sudden emergence of the genotype V in China and Korea was reported, suggesting expansion of its geographical distribution. Although studies on the genotype V are becoming more important, they have been limited partly due to lack of its infectious molecular clone. In this study, a plasmid carrying cDNA corresponding to the entire genome of JEV Muar strain, which belongs to genotype V, in the downstream of T7 promoter was constructed. Electroporation of viral RNA transcribed by T7 RNA polymerase (T7RNAP) in vitro from the plasmid led to production of progeny viruses both in mammalian and mosquito cells. Also, transfection of the infectious clone plasmid into mammalian cells expressing T7RNAP transiently or stably was demonstrated to generate infectious progenies. When the viral structural protein genes were partially deleted from the full-length cDNA, the subgenomic RNA transcribed in vitro from the modified plasmid was shown to replicate itself in mammalian cells as a replicon. The replicon carrying the firefly luciferase gene in place of the deleted structural protein genes was also shown to efficiently replicate itself and express luciferase in mammalian cells. Compared with the replicon derived from JEV genotype III (Nakayama strain), the genotype V-derived replicon appeared to be more tolerant to introduction of a foreign gene. The infectious clone and the replicons constructed in this study may serve as useful tools for characterizing JEV genotype V.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Flavivirus; Infectious clone; Japanese encephalitis virus; Subgenomic replicon

Mesh:

Substances:

Year:  2014        PMID: 25451067     DOI: 10.1016/j.virusres.2014.10.010

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence.

Authors:  Mélissanne de Wispelaere; Marie-Pascale Frenkiel; Philippe Desprès
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

2.  Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus.

Authors:  Chien-Yi Lu; Mann-Jen Hour; Ching-Ying Wang; Su-Hua Huang; Wen-Xiang Mu; Yu-Chun Chang; Cheng-Wen Lin
Journal:  Viruses       Date:  2017-04-10       Impact factor: 5.048

3.  Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251.

Authors:  Youki Ueda; Weilin Gu; Hiromichi Dansako; Hye-Sook Kim; Sayaka Yoshizaki; Nobuaki Okumura; Tomohiro Ishikawa; Hironori Nishitsuji; Fumihiro Kato; Takayuki Hishiki; Shinya Satoh; Koji Ishii; Michiaki Masuda; Kunitada Shimotohno; Masanori Ikeda; Nobuyuki Kato
Journal:  Biochem Biophys Rep       Date:  2018-06-01

4.  Recovery of a Far-Eastern Strain of Tick-Borne Encephalitis Virus with a Full-Length Infectious cDNA Clone.

Authors:  Penghui Li; Chen Yao; Ting Wang; Tong Wu; Wenfu Yi; Yue Zheng; Yuanjiu Miao; Jianhong Sun; Zhongyuan Tan; Yan Liu; Xiaowei Zhang; Hanzhong Wang; Zhenhua Zheng
Journal:  Virol Sin       Date:  2021-06-30       Impact factor: 6.947

5.  New reverse genetics and transfection methods to rescue arboviruses in mosquito cells.

Authors:  Thérèse Atieh; Antoine Nougairède; Raphaëlle Klitting; Fabien Aubry; Anna-Bella Failloux; Xavier de Lamballerie; Stéphane Priet
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

6.  Effects of the Japanese Encephalitis Virus Genotype V-Derived Sub-Viral Particles on the Immunogenicity of the Vaccine Characterized by a Novel Virus-Like Particle-Based Assay.

Authors:  Sarah Honjo; Michiaki Masuda; Tomohiro Ishikawa
Journal:  Vaccines (Basel)       Date:  2019-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.